Replies to post #37152 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

"70% ownership by tutes is a good starting point for shorting, especially when some tutes are hedgies. Why clear them of ulterior motives?"

Some may have purchased in order to short. But the majority were riding the wave, a red hot stock in a red hot immuno sector in a raging biotech market. It's easy to question that judgment in hindsight, but at the time everyone was believing AXS should be valued at at least $1.5 billion, based on Aduro alone, and many other similar companies valued in the billions. I, for one, believe ADXS is worth $1.5b today.